|
Acted for Shenzhen International Holdings Limited, a company listed on the Main Board of the Hong Kong Stock Exchange, in its issue of US$300 million (equivalent to approximately HK$2.34 billion) senior notes due 2017
|
|
Advising the joint Special Administrators of WorldSpreads Limited on an investigation into the group's affairs by the UK's Financial Services Authority and the de-listing of the company's parent from the London Stock Exchange.
|
|
$600 million registered debt exchange offer by Nasdaq-listed biopharma company
|
|
$950 million initial public offering by Nasdaq-listed biopharma company
|
|
$40 million aggregate US and offshore non-public offerings of securities by Canadian company dual-listed on NYSE Amex and TSX Venture Exchange
|
|
$10 million strategic acquisition of affiliated subsidiary by Nasdaq-listed clean tech company
|
|
$550 million business combination among three publicly-traded financial institutions
|
|
$2 billion merger and acquisition between two publicly-listed financial services companies
|
|
$75 million at-the-market equity offering by NYSE-listed health care REIT
|
|
$125 million common stock offering by unlisted company into Rule 144A institutional trading market
|